SCOLR Pharma, Inc. — Form D
SCOLR Pharma, Inc. of BELLEVUE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2011-06-23. The offering totals $1.8M, of which $1.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-06-23
- Form: D
- Accession: 0001461902-11-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.8M
- Amount sold: $1.0M
- Remaining: $749K
- Investors: 62
- Date of first sale: 2011-06-16
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-161766
Issuer
- Name: SCOLR Pharma, Inc.
- CIK: 0000934936
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 13400 NE 20TH STREET, BELLEVUE, WA, 98005
- Phone: 425-368-1050
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Michael N Taglich | Director | New York, NY |
| Michael N Taglich | Promoter | New York, NY |
| Wayne L Pines | Director | Bellevue, WA |
| Herbert L Lucas | Director | Bothell, WA |
| Stephen J Turner | Executive Officer | Bothell, WA |
| MaryLou W Arnett | Director | Bothell, WA |
| Richard M Levy | Executive Officer | Bothell, WA |
| Carl J Johnson | Director | Bothell, WA |
| Jeffrey B Reich | Director | Bothell, WA |
| Bruce S Morra | Director | Bothell, WA |
| Randall L-W Caudill | Director | Bothell, WA |
Other filings by this issuer (3)
More